Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · IEX Real-Time Price · USD
4.550
-0.160 (-3.40%)
At close: May 2, 2024, 4:00 PM
4.890
+0.340 (7.47%)
After-hours: May 2, 2024, 5:21 PM EDT

CELZ Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Net Income
-5.29-10.1419.21-36.33-8.48-13.66-2.66-0.77-0.03-0.03
Upgrade
Depreciation & Amortization
0.090.090.090.070.030.020.020.0100
Upgrade
Share-Based Compensation
0.040.070.60.17000.14000
Upgrade
Other Operating Activities
-2.872.19-22.1235.657.2412.581.610.310.020.01
Upgrade
Operating Cash Flow
-8.03-7.8-2.22-0.43-1.21-1.05-0.89-0.45-0.01-0.02
Upgrade
Change in Investments
3.55-10.0800000000
Upgrade
Other Investing Activities
-0.1---0.25----0.01--
Upgrade
Investing Cash Flow
3.45-10.080-0.25000-0.0100
Upgrade
Share Issuance / Repurchase
-0.2715.4714.760000.10.5500
Upgrade
Debt Issued / Paid
00-2.070.6911.340.580.130.010.02
Upgrade
Other Financing Activities
--0.16-------
Upgrade
Financing Cash Flow
-0.2715.4712.840.6911.340.680.680.010.02
Upgrade
Net Cash Flow
-4.85-2.410.630.01-0.220.29-0.210.22-00
Upgrade
Free Cash Flow
-8.03-7.8-2.22-0.43-1.21-1.05-0.89-0.45-0.01-0.02
Upgrade
Free Cash Flow Margin
-89198.72%-8800.19%-2524.99%-264.17%-732.99%-845.88%-18533.77%---
Upgrade
Free Cash Flow Per Share
-5.70-7.13-8.51-7.50-586.42-1346.91-6275.01-3551.97-606.05-717.10
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).